× Industry Reports Services Press Release Contact us About us

North America Bioreactors Market Share By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), Product Type (Single-use, Reusable), Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), By End-use (R&D Organizations, Biopharma Manufacturers, CMOs), Industry Analysis Report, Country Outlook (U.S. Canada), Application Potential, Competitive Market Share & Forecast, 2020 - 2026

Published Date: October 2020 | Publisher: Graphical Research Report ID: GR1222 | Delivery : PDF

Report Content

Chapter 1.     Methodology

1.1.   Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters

1.2.   Data sources 

1.3.   References & sources

1.3.1.  Secondary

1.3.2.  Primary

Chapter 2.     Executive Summary

2.1.   North America bioreactors industry summary, 2015 – 2026

2.1.1.  Country trends

2.1.2.  Product type trends

2.1.3.  Cell trends

2.1.4.  Molecule trends

2.1.5.  End-use trends

Chapter 3.     Industry Insights

3.1.   Industry segmentation

3.2.   Industry outlook, 2015 - 2026

3.3.   Major factor analysis

3.3.1.  Drivers

3.3.1.1.   Growing pharmaceutical and biotechnology industry in the region

3.3.1.2.      Rising government initiatives in the region

3.3.1.3.      Technological advancements in bioprocessing systems

3.3.1.4.      Rising demand for vaccines and cell-targeted therapies

3.3.2.  Restraints & challenges

3.3.2.1.   Limitations associated with single-use bioreactors

3.3.2.2.      Concerns regarding extractables and leachables

3.3.2.3.      Stringent regulatory framework

3.4.   Analysis of COVID-19 impact on the industry

3.5.   Porter’s analysis

3.6.   Competitive review, 2019

3.7.   PEST analysis

Chapter 4.         North America Bioreactors Market Share, By Product Type

4.1.   Key trends in North America bioreactors, by product type

4.2.   Single-use

4.2.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

4.3.   Reusable

4.3.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

Chapter 5.         North America Bioreactors Market Size, By Cell

5.1.   Key trends in North America bioreactors, by cell

5.2.   Mammalian cells

5.2.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

5.3.   Bacterial cells

5.3.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

5.4.   Yeast cells

5.4.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

5.5.   Others

5.5.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

Chapter 6.         North America Bioreactors Market Growth, By Molecule

6.1.   Key trends in North America bioreactors, by molecule

6.2.   Monoclonal antibodies

6.2.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

6.3.   Vaccines

6.3.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

6.4.   Recombinant proteins

6.4.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

6.5.   Stem cells

6.5.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

6.6.   Gene therapy

6.6.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

6.7.   Others

6.7.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

Chapter 7.         North America Bioreactors Market Forecast, By End-use

7.1.   Key trends in North America bioreactors, by End-use

7.2.   R&D Organizations

7.2.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

7.3.   Biopharma Manufacturers

7.3.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

7.4.   CMOs

7.4.1.  Market estimates and forecast, by country, 2015 – 2026 (USD Million)

Chapter 8.         North America Bioreactors Market Trends, By Country

8.1.   Key trends in North America bioreactors, by country

8.2.   U.S.

8.2.1.   Market estimates and forecast, by product type, 2015 – 2026 (USD Million)

8.2.2.  Market estimates and forecast, by cells, 2015 – 2026 (USD Million)

8.2.3.  Market estimates and forecast, by molecule, 2015 – 2026 (USD Million)

8.2.4.  Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

8.3.   Canada

8.3.1.   Market estimates and forecast, by product type, 2015 – 2026 (USD Million)

8.3.2.  Market estimates and forecast, by cells, 2015 – 2026 (USD Million)

8.3.3.  Market estimates and forecast, by molecule, 2015 – 2026 (USD Million)

8.3.4.  Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

Chapter 9.     Company Profiles

9.1.   Applikon Biotechnology, Inc. (Getinge AB)

9.1.1.   Business overview

9.1.2.  Financial data

9.1.3.  Product landscape

9.1.4.  Strategic outlook

9.2.   Eppendorf AG

9.2.1.   Business overview

9.2.2.  Financial data

9.2.3.  Product landscape

9.2.4.  Strategic outlook

9.3.   Cytiva

9.3.1.   Business overview

9.3.2.  Financial data

9.3.3.  Product landscape

9.3.4.  Strategic outlook

9.4.   GEA Group Aktiengesellschaft

9.4.1.   Business overview

9.4.2.  Financial data

9.4.3.  Product landscape

9.4.4.  Strategic outlook

9.5.   Merck Group

9.5.1.   Business overview

9.5.2.  Financial data

9.5.3.  Product landscape

9.5.4.  Strategic outlook

9.6.   Pierre Guerin Sas

9.6.1.   Business overview

9.6.2.  Financial data

9.6.3.  Product landscape

9.6.4.  Strategic outlook

9.7.   PBS Biotech

9.7.1.   Business overview

9.7.2.  Financial data

9.7.3.  Product landscape

9.7.4.  Strategic outlook

9.8.   Sartorius Group

9.8.1.   Business overview

9.8.2.  Financial data

9.8.3.  Product landscape

9.8.4.  Strategic outlook

9.9.   Shanghai Bailun Biotechnology co., Ltd.

9.9.1.   Business overview

9.9.2.  Financial data

9.9.3.  Product landscape

9.9.4.  Strategic outlook

9.10. Solaris Biotechnology Srl

9.10.1. Business overview

9.10.2.          Financial data

9.10.3.          Product landscape

9.10.4.          Strategic outlook

9.11. Thermo Fisher Scientific

9.11.1. Business overview

9.11.2.          Financial data

9.11.3.          Product landscape

9.11.4.          Strategic outlook
 


Select License

North America Bioreactors Market Size & Share | 2020 to 2026


Related Reports
Why Choose us?
  • On-Time Delivery - logo On-Time Delivery
  • Assured Quality - logo Assured Quality
  • Industry Experts - logo Industry Experts
  • Payment Security - logo Payment Security
Share Social-media